# FDA recall Z-0421-2022

> **Migo Trading LLC** · Class II · device recall initiated 2021-11-04.

## Product

FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test

## Reason for recall

Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA).  This product has not been authorized for emergency use and the test cannot be determined to be adequately validated for the stated intended use.

## Distribution

NY

## Key facts

- **Recall number:** Z-0421-2022
- **Recalling firm:** Migo Trading LLC
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2021-11-04
- **Report date:** 2022-01-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dayton, NV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0421-2022

## Citation

> AI Analytics. FDA recall Z-0421-2022. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/Z-0421-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*